Ballentine Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.4M Sell
3,664
-399
-10% -$153K 0.02% 262
2025
Q1
$1.4M Sell
4,063
-6
-0.1% -$2.07K 0.02% 236
2024
Q4
$1.22M Sell
4,069
-44
-1% -$13.2K 0.02% 246
2024
Q3
$1.67M Buy
4,113
+107
+3% +$43.5K 0.03% 198
2024
Q2
$1.29M Buy
4,006
+127
+3% +$40.8K 0.02% 219
2024
Q1
$1.29M Buy
3,879
+38
+1% +$12.7K 0.02% 203
2023
Q4
$1.04M Buy
3,841
+675
+21% +$183K 0.02% 223
2023
Q3
$779K Sell
3,166
-18
-0.6% -$4.43K 0.02% 231
2023
Q2
$966K Buy
3,184
+81
+3% +$24.6K 0.02% 201
2023
Q1
$818K Buy
3,103
+124
+4% +$32.7K 0.02% 222
2022
Q4
$715K Sell
2,979
-26
-0.9% -$6.24K 0.02% 225
2022
Q3
$553K Buy
3,005
+439
+17% +$80.8K 0.02% 231
2022
Q2
$431K Buy
2,566
+38
+2% +$6.38K 0.02% 260
2022
Q1
$634K Buy
2,528
+51
+2% +$12.8K 0.02% 228
2021
Q4
$637K Hold
2,477
0.02% 236
2021
Q3
$601K Buy
2,477
+18
+0.7% +$4.37K 0.02% 212
2021
Q2
$508K Buy
2,459
+6
+0.2% +$1.24K 0.02% 231
2021
Q1
$462K Sell
2,453
-118
-5% -$22.2K 0.02% 233
2020
Q4
$423K Sell
2,571
-396
-13% -$65.2K 0.02% 235
2020
Q3
$370K Buy
2,967
+390
+15% +$48.6K 0.02% 249
2020
Q2
$250K Sell
2,577
-61
-2% -$5.92K 0.01% 309
2020
Q1
$238K Buy
2,638
+144
+6% +$13K 0.01% 288
2019
Q4
$368K Sell
2,494
-5
-0.2% -$738 0.02% 267
2019
Q3
$301K Sell
2,499
-102
-4% -$12.3K 0.01% 291
2019
Q2
$351K Buy
2,601
+1,004
+63% +$135K 0.02% 265
2019
Q1
$209K Buy
+1,597
New +$209K 0.01% 305
2018
Q4
Sell
-1,603
Closed -$222K 348
2018
Q3
$222K Buy
+1,603
New +$222K 0.01% 314